Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07726966) titled 'Betacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial' on July 21.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Southwest Hospital, China
Condition:
Rectum Cancer
Anastomotic Leak
Intervention:
Dietary Supplement: Betacyanin
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 20, 2026
Target Sample Size: 120
Countries of Recruitment:
China
To know more, visit...